Description / anti-human TRAIL/Apo2L polyclonal antibody
TNF-related apoptosis-inducing ligand (TRAIL) is a ligand molecule which induces apoptosis. It is a type II transmembrane protein with homology to other members of the tumor necrosis factor family. In humans, the gene that encodes for TRAIL is located at chromosome 3q26. TRAIL binds to the death receptors, DR4 and DR5. The process of apoptosis is caspase-8-dependent. This protein preferentially induces apoptosis in transformed and tumor cells, but does not appear to kill normal cells although it is expressed at a significant level in most normal tissues.
More Information
Size | 200 µg |
---|---|
Source | Rabbit |
Clone Nr. | Rabbit IgG |
Species Reactivity | Human |
Formulation | lyophilized from PBS |
Buffer | PBS |
Reconstitution | Centrifuge vial prior to opening. Reconstitute in sterile water to a concentration of 0.1-1.0 mg/ml. |
Stability and Storage | The lyophilized antibody is stable for at least 2 years at -20°C. After sterile reconstitution the antibody is stable at 2-8°C for up to 6 months. Frozen aliquots are stable for at least 6 months when stored at -20°C. Addition of a carrier protein or 50% |
Preparation | Produced from sera of rabbits pre-immunized with highly pure (>98%) recombinant hsTRAIL/Apo2L. Anti-Human sTRAIL/Apo2L specific antibody was purified by affinity chromatography employing immobilized hsTRAIL/Apo2L matrix. |
Antigen | recombinant human TRAIL/ApoL2 |
Application | WB |
Synonyms | TNFSF10; TL2; APO2L; CD253; TRAIL; Apo-2L |
Uniprot ID | P50591 |
Protein RefSeq | NP_003801.1 |
mRNA RefSeq | NM_003810.3 |